C40 - PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients

Autor: Cianniello, D., Prudente, A., Caputo, R., Piezzo, M., Riemma, M., Savastano, B., Cocco, S., Licenziato, M., De Stefano, B., Di Gioia, G., Fusco, G., Buonfanti, G., Gravina, A., Landi, G., Di Rella, F., Pacilio, C., Nuzzo, F., Iodice, G., De Laurentiis, M., Del Prete, S.

Publikováno v: In Annals of Oncology October 2017 28 Supplement 6:vi36-vi36

Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease

Autor: Giovanna D'Arcangelo a, Daniele Grossi a, Giovanna De Chiara b, Maria Chiara de Stefano b, Giancarlo Cortese c, Gennaro Citro c, Stefano Rufini d, Virginia Tancredi a, Daniela Merlo b, e, Claudio Frank f

Publikováno v: Brain research (Online) 1396 (2011): 11–19.
info:cnr-pdr/source/autori:Giovanna D'Arcangelo a, Daniele Grossi a, Giovanna De Chiara b, Maria Chiara de Stefano b, Giancarlo Cortese c, Gennaro Citro c, Stefano Rufini d, Virginia Tancredi a, Daniela Merlo b, e, Claudio Frank f,/titolo:Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease/doi:/rivista:Brain research (Online)/anno:2011/pagina_da:11/pagina_a:19/intervallo_pagine:11–19/volume:1396

Niemann-Pick Type C Disease (NPCD) is a progressive neurodegenerative disorder characterized by accumulation of free cholesterol, sphingomyelin, glycosphingolipids (GSLs) and sphingosine in lysosomes, mainly due to a mutation in the NPC1 gene. One of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73a96974d95879745e0cec20e6b6158
http://www.cnr.it/prodotto/i/223189

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.